Castleark Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,980
| Closed | -$1.47M | – | 279 |
|
|
2024
Q1 | $1.47M | Buy |
+20,980
| New | +$1.47M | 0.06% | 192 |
|
|
2023
Q2 | – | Sell |
-34,625
| Closed | -$1.22M | – | 285 |
|
|
2023
Q1 | $1.22M | Sell |
34,625
-50,680
| -59% | -$1.78M | 0.06% | 180 |
|
|
2022
Q4 | $3.91M | Sell |
85,305
-76,790
| -47% | -$3.52M | 0.2% | 116 |
|
|
2022
Q3 | $7.85M | Buy |
162,095
+9,240
| +6% | +$448K | 0.44% | 47 |
|
|
2022
Q2 | $6.01M | Sell |
152,855
-24,620
| -14% | -$967K | 0.32% | 67 |
|
|
2022
Q1 | $6.53M | Buy |
177,475
+27,480
| +18% | +$1.01M | 0.28% | 86 |
|
|
2021
Q4 | $6.84M | Buy |
+149,995
| New | +$6.84M | 0.25% | 97 |
|